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Aims: Previous comparisons of cognitive decline among patients with bipolar disorder (BD)
and schizophrenia (SZ) have found somehow quite similar profiles of deficits, but results
have varied between studies. Therefore an extensive and thoughtful systematic review of
the matter is warranted.
Methods: Studies were found through systematic search (PubMed) following PRISMA
guidelines. To be included, studies must have assessed the following cognitive functions:
executive functions, memory, IQ, attention-concentration, and perceptuomotor function.
In order to make comparison between the two entities, studies should include BD patients
with operationally defined euthymia, schizophrenic patients in remission, and third group
of healthy control patients. Comparisons were made after controlling for years of schooling
and residual affective symptoms.
Results:We found that overall both SZ and BD patients present deficits on all neurocogni-
tive measures compared to healthy controls. In particular, SZ patients show more severe
and pervasive cognitive deficits while BD patients present a milder and more confined
impairment. In addition, evidence from the literature suggests that SZ and BD patients
share a similar cognitive impairment profile with different degrees of deficits.Therefore, the
difference between the two groups seems to be more quantitative (degree of deficit) rather
than qualitative (profile), supporting a dimensional approach to the two clinical entities. Lim-
itations of the present review includes the impossibility to control for effects of medication,
varying time required for assessment across studies, illness diagnosis reliability, and course
severity.
Conclusion: Patients with BD might exhibit a cognitive impairment that could be simi-
lar to SZ in terms of their profile, although patients with SZ may have more severe and
widespread impairments.
Keywords: systematic review, cognitive impairment, schizophrenia, bipolar disorder, working memory
INTRODUCTION
In his landmark paper “The Diagnosis and Prognosis of Dementia
Praecox” presented in Heidelberg in 1898 (1), German psychiatrist
Emil Kraepelin discussed the results of his methodical observation
of patients by stating that in dementia praecox “The prognosis,
however, is really by no means simple. Whether dementia praecox
is susceptible of a complete and permanent recovery . . . is still very
doubtful, if not impossible. But improvements are not at all unusual
. . .. It is amore seriousmatter that inmost of these cases the improve-
ment is only temporary, and that such patients are in great danger
of relapsing sooner or later, without any particular cause, and then
generally suffer more serious injury from their illness.” He distin-
guished dementia praecox from an apparently less severe course
illness that was reported in 13% of his patients. The idea that an
illness with a course potentially severe as dementia praecox and a
“spontaneous recovery” was difficult to accept in the nineteenth
century Germany psychiatry. In addition Kraepelin saw Dementia
Praecox as a “disease process in the brain, involving the cortical neu-
rones [and brought about] by an autointoxication . . . as a result of
a disorder of metabolism” (2).
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Although the course of illness, as understood by Kraepelin,
pointed to a differentiate Manic Depressive Insanity (current bipo-
lar disorder – BD) from Dementia Praecox (current Schizophre-
nia – SZ) in terms of degree of cognitive deterioration (Dementia),
research in the last decade has begun to shed some light into the
long term course of BD. In addition, they have also reported that in
BD different cognitive domains deteriorate in remarkable similar
ways as SZ. In other words, although Kraepelin’s great insight has
led to the proper qualitative differentiation between these remark-
ably similar illnesses, recent prospective observational studies (3)
have shown that BD and SZ share similar dimensional charac-
teristics in terms of neurocognitive domains. Data from recent
meta-analysis conducted in BD and SZ are in line with these find-
ings. Depp et al. and Fett et al. reported a similar mean correlation
between overall neurocognitive ability and everyday functioning
(4, 5). Mann-Wrobel et al., similarly though less severely than
in SZ (6), reported a broadly generalized cognitive impairment
in euthymic BD patients with verbal ability as a possible area
of preserved performance (7). Neuropsychological deficits rep-
resent a core feature of BD and SZ; however, their onset and
progression differ between diagnostic groups. (8). For instance,
although cognitive deterioration can appear from the outset in
both disorders, in BD, as compared to SZ, it follows a progressive
longitudinal worsening related to the number and the intensity of
mood episodes (9). This might reflect different brain structural
and functional alterations related to BD exacerbations. Imaging
studies have shown alterations in regions related to emotional and
cognitive functioning. A meta-analysis by Bora et al showed gray
matter reductions are more circumscribed to these areas when
controlling by gender. Modest differences between both disorders
were found, with SZ patients showing higher dorsomedial and dor-
solateral prefrontal cortex affectation compared with BD (10). In
functional studies frontal-subcortical structures show abnormali-
ties in both disorders with common hyper-activation of emotional
limbic regions in relation to prefrontal-cortical regions. In addi-
tion, BD has shown more pronounced chronic hypo-activation of
ventral-medial regions (11). The end result of this apparent con-
nectivity abnormality may result in a glutamatergic transmission
excess in key memory and processing regions with concomitant
excitotoxicity and neurocognitive sequelae in BD (12). Moreover,
modern techniques in molecular biology and neuroanatomical
immunocytochemistry have established that both disorders share
neuronal pathological markers in brain areas as hippocampus that
correlate with neurocognitive sequelae (13, 14).
The aim of this systematic review is twofold: (i) describe and
compare the neuropsychological dysfunction between BD and SZ
patients as addressed by included studies; (ii) investigate the course
of illness to better differentiate and predict onset and progression
of these two disorders.
METHODS
To identify studies reporting cognitive impairment in BD and
SZ we searched PubMed database for the period between
2008/01/31 and 2013/01/31, following PRISMA guideline rec-
ommendations (15). We combined the search strategy of free
text terms and exploded MESH headings as following: [((SZ
AND bipolar AND control) AND (neurocogniti∗ OR cognitive
OR neuropsycholog∗)) NOT (Gen∗(MeSH Major Topic) OR
Neuroimag∗(MeSH Major Topic))]. Additional studies were iden-
tified by reviewing the references of each article found, method
deemed appropriated by recent articles seeking similar objec-
tives as ours (4, 10). The search cutoff date was the last day of
January 2013. Criteria for inclusion in this study were:(a) publi-
cation Full text available in English, (b) inclusion of a BD group
with operationally defined euthymia, a schizophrenic group in
remission and a healthy comparison group (studies that did not
directly compare the three groups were excluded), (c) recruitment
of adult population (18 years or older), (d) meta-analysis, con-
trolled clinical trial, systematic reviews, comparative study, and
randomized controlled trial, (e) assessment of the following cog-
nitive functions: executive functions, memory, IQ or educational
level, attention-concentration, and perceptuomotor function. Key
words and application of inclusion/exclusion criteria resulted
in 18 papers. Additionally we performed a second search using
the algorithm (“premorbid” OR “pre-morbid” OR “at risk” OR
“prodrom”) AND (schizoph∗ AND bipolar) AND (cognition OR
neurocogniti∗ OR neuropsycholog∗) AND [Meta-Analysis(ptyp)
OR Randomized Controlled Trial(ptyp) OR Review(ptyp) AND
“last 5 years” (PDat)]. This algorithm yielded to one additional
review (8) with same aims as ours. Additional 22 records were
identified trough bibliographic cross-referencing. After remov-
ing 1 duplicate study, 39 records were screened. Application of
inclusion/exclusion criteria resulted in exclusion of 29 studies: 16
were out the search interval dates, 2 lacked either schizophrenic or
euthymic bipolar group, and 1 lacked of a control group, 3 were
focused on differential neuroimaging. 2 were focused on genetics,
and 4 on the effect of treatment alternatives (CBT, Befriending,
ECT, and Ziprasidone), 1 studied only bipolar patients and dis-
cussed comparatively with SZ. As shown in Table 1, key words
and application of inclusion/exclusion criteria finally resulted in
10 papers.
Two reviewers extracted all data independently (Sergio A. Bar-
roilhet and Paul A. Vöhringer). Discrepancies between reviewers
were resolved through discussion until consensus was reached.
RESULTS
Findings from studies that analyzed the cognitive profile of
patients with SZ and BD when compared with healthy controls
(HC) are summarized in Table 2.
Reviewed studies found that overall both SZ and BD patients
present deficits on almost all neurocognitive measures compared
to HC, with few exceptions in some domains (16, 17) for some
sample comparisons (18, 19). In particular, SZ patients show more
severe and pervasive cognitive deficits while BD patients present
a milder and more confined impairment (20). In addition, evi-
dence from the literature suggests that SZ and BD patients share
a similar cognitive impairment profile with different degrees of
deficits. Therefore, the difference between the two groups seems
to be more quantitative (degree of deficit) rather than qualitative
(profile), supporting a dimensional approach to the two clinical
entities (21).
With regard to the course of the disease, authors report that in
BD patient’s cognitive deficits persist during periods of euthymia,
which implies that cognitive deficits are not uniquely associated
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Table 1 | Included studies.
Study Sample characteristics Materials
Barrett et al.
(17) in
Lewandowski
et al. (8)
SZ (SZ=44, SZA=2, age=29) Global intellectual functioning: WASI two-test version, vocabulary, and matrix reasoning
BD/mania (n=32, age=37) Verbal attention and working memory (digit span forward/backward from WMS)
HC (n=67, mean age=32) Spatial attention: Corsi Block-Tapping Test
Verbal memory: paired associates WMS
Visual memory: ROCFT
Response inhibition and attentional set shifting: Hayling and Brixton Tests
Verbal fluency: COWATT
Language: Perin’s Spoonerisms
Callosal function: TFL
Brissos et al.
(16)
SZ remitted (n=23, mean age=37) Attention and mental control: WMS digit span
BD type I euthymic (n=30, mean age=36) Perceptual-motor skills: SDMT and TMT-A
HC (n=23, mean age=37) Executive functions: SCT and SCWT, TMT-B, and ToH
Verbal fluency: COWA
Verbal abstraction: WAIS: comprehension and similarities subtests
Visuo-spatial attention: Bell’s Test
Memory function: WAIS: information subtest, WMS: logical memory
Brissos et al.
(20)
SZ remitted (n=35, mean age=40)
BD type I euthymic (HPS+=44, mean
age=39; HPS−=35, mean age 38)
HC (n=50, mean age=34)
Attention and mental control: mental tracking, digit span forward (WMS), Bell’s Test
Processing speed: Symbol Digit Modalities Test, TMT-A
Executive functions: Digit Span backward, SCT and SCWT, TMT-B, ToH,
COWAT – animal naming
Test of verbal fluency: WAIS-R comprehension and similarities subtests
Verbal memory: WAIS-R – information subtest, WMS – logical memory
Gogos et al.
(24)
SZ non-psychotic (n=38, mean age=43) Immediate memory/learning, visuo-spatial ability, language, attention, and delayed
memory: RBANS domain scores and total scoreBD euthymic (n=40, mean age=42)
HC (n=43, mean age=41)
Joshua et al.
(18)
SZ not acute phase (n=39, mean age=42) Executive functioning (response initiation, response suppression, and an error pattern):
HSCTBD not acute phase (n=40, mean age=42)
HC (n=44, mean age=41)
Rossell and
Batty (25)
SZ (n=32, mean age=36) Word comprehension across grammatical categories, i.e., nouns, verbs, and adjectives
BD/mania (n=28, mean age=39)
HC (n=32, mean age=37)
Sanchez-Morla
et al. (23)
BD (n=73, mean age=44)
(BD I=55, BD II=18)
SZ (n=88, mean age=39)
HC (n=67, mean age=44)
Executive function. Concept formation and shifting: WCST. Planning and problem
solving: ToH. Verbal fluency: COWAT. Semantic fluency: Animal Naming Test
Executive control: TMT-B and SCWT. Verbal working memory: WAIS-R digit subtest,
digits backward. Sustained attention. Degraded stimulus CPT
Verbal learning and memory: CVLT
Visual memory: ROCFT
Simonsen et
al. (19)
SZ (n=102, mean age=32)
SZA (n=27, mean age=34)
BD I or II (n=136, mean age=36)
BD with psychosis=75
HC (n=280, mean age=36)
Verbal learning and memory: Logical Memory Test (WMS-III) and CVLT-II, with sub score
measures of verbal learning and recall
Processing speed: Digit Symbol Test WAIS-III
Working memory: Digit Span Test – backward (WAIS-III) and WM-MA
Verbal fluency: Verbal Fluency Test (D-KEFS), with measures of phonetic fluency,
semantic fluency, and semantic fluency set shift
Interference: Color Word Interference Test (D-KEFS), with subscore for interference
control and interference set shift
(Continued)
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Table 1 | Continued
Study Sample characteristics Materials
Wobrock et al.
(22)
SZ first episode (n=11, mean age=30)
SZ chronic (n=13, mean age=35)
BD (n=18, mean age=42)
HC (n=23, mean age=30)
Deficits in attention, speed processing, and psychomotor performance: RT1 single
stimulus and RT3 compound stimulus (subtests of the WTS)
Divided attention task: “Geteilte Aufmerksamkeit” (subtest of TAP)
Psychomotor performance and speed: ZVT, a test similar to the TMT-A
Attention and working memory: digit span task “Zahlennachsprechen” (a subtest of the
HAWIE), working memory test “Arbeitsgedächtnis” (subtest of the TAP)
Visuo-spatial working memory: Corsi Block-Tapping Test (of WTS battery), Test of Spatial
Recognition Memory (CANTAB)
Verbal learning and memory: VLMT, similar to the CVLT
Non-verbal learning capacity: NVLT, subtest of WTS
Verbal fluency: RWT
Deficits in concept formation, cognitive flexibility, and executive functions: WCST and
TOL
Intermodal comparison: “Intermodaler Vergleich” (subtest of the TAP). Interference:
“Stroop” task (subtest of the WTS), word (Stroop-LI) and color (Stroop-BI) interference
conditions
Zanelli et al.
(28)
SZ (n=65, mean age=27) Learning and memory: RAVLT, visual reproduction subtest of the WMS–R
BD (n=37, mean age=28) Executive functions and working memory: TMT-B; LNST, RCPM series AB and B
OP (n=46, mean age=29) Attention, concentration, and processing speed:TMT-A and WAIS-R digit symbol subtest
Depressive psychosis (n=39, mean
age=37)
HC (n=177, mean age=37)
Language: WAIS-R category fluency (semantic and letter fluency tasks)
Visual-spatial perception and organization: set A of RCPM and WAIS-R Block Design
Verbal intelligence: WAIS-R vocabulary and comprehension subtests
HC, healthy controls; SZ, schizophrenia; BD, bipolar disorder; SZA, schizoaffective disorder; SZF, schizophreniform disorder; HPS+, with history of psychosis; HPS−,
without history of psychosis; OP, other psychotic disorders (persistent delusional disorders, acute and transient psychotic disorders, other non-organic psychotic
disorders, and unspecified non-organic psychosis).
CANTAB, Cambridge NeuropsychologicalTest Automated Battery; COWAT, Controlled Oral Word AssociationTest; CPT, Continuous PerformanceTest; CVLT, California
Verbal Learning Test; D-KEFS, Delis–Kaplan Executive Function System; DP, Depressive Psychosis; HSCT, Hayling Sentence Completion Test; LNST, Letter-Number
Span Test; NVLT, “Non-verbaler Lerntest”; RAVLT, Rey Auditory Verbal Learning Test; RBANS, Repeatable Battery for the Assessment of Neuropsychological Status;
RCPM, Raven’s Colored Progressive Matrices; ROCFT, Rey–Osterrieth Complex FigureTest; RT1, “Reaktionstest” single stimulus; RT3, “Z” compound stimulus; RWT,
“Regensburger Wortflüssigkeits-Test”; SCT, Stroop Color Test; SCWT, Stroop Color-Write Test; TFLT, Tactile Finger Localization Test; SDMT, Symbol Digit Modalities
Test; TAP, “Aufmerksamkeitsprüfung” test battery; TMT-A, Trail Making Test part A; TMT-B, Trail Making Test part B; ToH, Hanoi Towers Test; TOL, Tower of London Test;
VLMT, “Verbaler Lern und Merkfähigkeitstest”; Voc, WAIS Vocabulary subtest; WAIS-R/-III, Wechsler Adult Intelligence Scale (Revised/Third Edition); WASI, Wechsler
Abbreviated Scale of Intelligence; WCST, Wisconsin Card Sorting Test; WM, working memory; WM-MA, Working Memory-Mental Arithmetic Test; WMS, Wechsler
Memory Scale; WTS, Wiener Test System; ZVT, “Zahlenverbindungstest.”
with the clinical manifestations of BD. In this context, neurocog-
nitive impairment would be considered a trait rather than a
state-specific feature.
EXECUTIVE FUNCTIONS
Cognitive flexibility, inhibitory control, working memory and
fluency, among others, were considered.
To analyze executive functions authors used tests that assess
cognitive flexibility through attention shifting tasks (Trail Making
Test – Part B; TMT-B, Brixton Spatial Anticipation Test; BSAT,Wis-
consin Card Sorting Test; WCST) and tests that assess inhibitory
control through selective attention tasks (Stroop Color Test; SCT,
Stroop Color-Write Test; SCWT, Hayling Sentence Completion
Test; HSCT).
With regard to cognitive flexibility, SZ patients showed more
perseverative responses with poorer WCST scores as compared to
BD patients and HC after adjusting for gender, age, and duration
of education (p= 0.002 and 0.026, respectively) (22).
Brissos et al., Joshua et al., Sanchez-Morla et al., reported that
BD patients performed intermediately between SZ patients and
HC on stimulus inhibition and speed information processing (16,
18, 23).
Studies investigating working memory used a variety of dif-
ferent tests (Attention Test Battery; TAP, Digit Spam Test; WAIS-
III, Working Memory-Mental Arithmetic Test; WM-MA). They
showed that SZ patients performed poorly as compared to HC
(19, 22). In addition, Sanchez-Morla et al. emphasize significant
differences between SZ and BD patients with worse results in
the former group (Digits Backward – WAIS-R: 4.5 (±1.9) and
4.9 (±1.9), respectively, p< 0.003; after adjusting for age, years
of education, gender, subclinical depressive symptomatology, and
premorbid IQ) (23).
Similar trends were reported when analyzing verbal fluency;
SZ patients performing worse relative to HC (Verbal Fluency
Test, D-KEFS: phonetic: 37.8 (±12.3) vs. 44.9 (±10.8), seman-
tic: 39.0 (±10.6) vs. 48.1 (±8.4), set shifting: 12.0 (±2.5) vs. 14.7
Frontiers in Psychiatry | Schizophrenia August 2013 | Volume 4 | Article 87 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vöhringer et al. Cognitive comparison between bipolar disorder and schizophrenia
Ta
b
le
2
|F
in
d
in
g
s.
S
tu
d
y
E
xe
cu
ti
ve
fu
n
ct
io
n
s
an
d
la
n
g
u
ag
e
M
em
o
ry
A
tt
en
ti
o
n
Pe
rc
ep
tu
o
m
o
to
r
fu
n
ct
io
n
s
IQ
N
o
te
s
B
ar
re
tt
et
al
.
(1
7)
in
Le
w
an
do
w
sk
i
et
al
.(
8)
B
D
,S
Z
<
H
C
,i
m
pa
ire
d
on
ex
ec
ut
iv
e
fu
nc
tio
ni
ng
an
d
la
ng
ua
ge
by
fir
st
ep
is
od
e
S
Z
<
B
D
<
H
C
on
re
sp
on
se
in
hi
bi
tio
n,
ve
rb
al
flu
en
cy
an
d
ca
llo
sa
lf
un
ct
io
ni
ng
B
D
,S
Z
<
H
C
,i
m
pa
ire
d
in
ve
rb
al
an
d
vi
su
al
m
em
or
y
pe
rf
or
m
an
ce
s
by
fir
st
ep
is
od
e
B
D
pt
ar
e
re
po
rt
ed
to
ha
ve
in
te
rm
ed
ia
te
re
su
lts
be
tw
ee
n
th
e
tw
o
gr
ou
ps
N
o
di
ffe
re
nc
es
B
D
an
d
S
Z
pt
di
sc
lo
se
d
lo
w
er
pr
em
or
bi
d
an
d
cu
rr
en
t
IQ
sc
or
es
co
m
pa
re
d
to
H
C
S
Z
w
ith
“p
re
se
rv
ed
”
IQ
=
B
D
:s
im
ila
r
“p
at
te
rn
”
of
de
fic
its
B
D
>
S
Z
in
cu
rr
en
t
IQ
sc
or
e
B
ris
so
s
et
al
.
(1
6)
B
D
,S
Z
<
H
C
in
st
im
ul
us
in
hi
bi
tio
n,
an
d
in
fo
rm
at
io
n
pr
oc
es
si
ng
B
D
pt
pe
rf
or
m
ed
in
te
rm
ed
ia
te
ly
be
tw
ee
n
S
Z
pt
an
d
H
C
al
th
ou
gh
di
ffe
re
nc
es
di
dn
’t
re
ac
h
st
at
is
tic
al
si
gn
ifi
ca
nc
e
N
o
di
ffe
re
nc
es
S
Z
<
B
D
,H
C
on
si
m
pl
e
au
to
m
at
ic
an
d
at
te
nt
io
na
l
pr
oc
es
si
ng
A
tt
en
tio
n
de
fic
its
in
S
Z
an
d
B
D
pt
pe
rs
is
te
d
du
rin
g
th
e
en
tir
e
co
ur
se
of
th
e
di
se
as
e
in
cl
ud
in
g
pe
rio
ds
of
eu
th
ym
ia
B
D
,S
Z
<
H
C
on
pe
rc
ep
tu
al
-m
ot
or
sk
ill
s
N
ot
as
se
ss
ed
A
lth
ou
gh
no
t
si
gn
ifi
ca
nt
ly
,B
D
pt
pe
rf
or
m
ed
in
te
rm
ed
ia
te
ly
be
tw
ee
n
pt
w
ith
S
Z
an
d
H
C
B
ris
so
s
et
al
.
(2
0)
S
Z
<
B
D
<
H
C
on
m
en
ta
lc
on
tr
ol
,
pr
oc
es
si
ng
sp
ee
d,
ex
ec
ut
iv
e
fu
nc
tio
ns
(o
nl
y
qu
an
tit
at
iv
e,
no
t
qu
al
ita
tiv
e
di
ffe
re
nc
es
)
S
Z,
B
D
<
H
C
on
ve
rb
al
m
em
or
y
fu
nc
tio
n
S
Z
>
B
D
H
P
S
+,
H
P
S
−,
H
C
in
sl
ow
ne
ss
an
d
pe
rs
ev
er
at
io
n
in
in
co
ng
ru
en
t
ta
sk
s
is
in
te
rp
re
te
d
as
a
pr
ox
y
of
de
fic
ie
nt
in
hi
bi
to
ry
co
nt
ro
l,
st
ro
ng
ly
re
la
te
d
w
ith
po
or
se
le
ct
iv
e
at
te
nt
io
n
N
ot
as
se
ss
ed
C
on
tr
ol
le
d
fo
r
ed
uc
at
io
na
ll
ev
el
,
no
t
IQ
B
D
H
P
S
+
w
as
no
t
as
so
ci
at
ed
w
ith
m
or
e
se
ve
re
co
gn
iti
ve
im
pa
irm
en
t
du
rin
g
eu
th
ym
ia
G
og
os
et
al
.
(2
4)
S
Z,
B
D
<
H
C
on
la
ng
ua
ge
S
Z
<
B
D
<
H
C
on
im
m
ed
ia
te
m
em
or
y/
le
ar
ni
ng
S
Z
<
B
D
,H
C
on
de
la
ye
d
m
em
or
y
S
Z
<
B
D
,H
C
on
vi
su
o-
sp
at
ia
l
an
d
de
la
ye
d
m
em
or
y
S
Z
<
H
C
on
at
te
nt
io
n
S
Z
=
B
D
on
at
te
nt
io
n
A
tt
en
tio
n
de
fic
its
in
S
Z
an
d
B
D
pa
tie
nt
s
pe
rs
is
te
d
du
rin
g
th
e
en
tir
e
co
ur
se
of
th
e
di
se
as
e
in
cl
ud
in
g
pe
rio
ds
of
eu
th
ym
ia
.S
im
ila
r
re
su
lts
fo
un
d
us
in
g
di
ffe
re
nt
te
st
s
th
at
re
qu
ire
d
ke
ep
in
g
at
te
nt
io
n
fo
cu
se
d
fo
r
an
ex
te
nd
ed
am
ou
nt
of
tim
e
N
ot
as
se
ss
ed
M
at
ch
ed
fo
r
IQ
S
Z
<
B
D
,H
C
on
ov
er
al
lc
og
ni
tiv
e
fu
nc
tio
ni
ng
(C
on
tin
ue
d)
www.frontiersin.org August 2013 | Volume 4 | Article 87 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vöhringer et al. Cognitive comparison between bipolar disorder and schizophrenia
Ta
b
le
2
|C
o
n
ti
n
u
ed
S
tu
d
y
E
xe
cu
ti
ve
fu
n
ct
io
n
s
an
d
la
n
g
u
ag
e
M
em
o
ry
A
tt
en
ti
o
n
Pe
rc
ep
tu
o
m
o
to
r
fu
n
ct
io
n
s
IQ
N
o
te
s
Jo
sh
ua
et
al
.
(1
8)
S
Z
<
B
D
,c
on
tr
ol
on
ov
er
al
lH
S
C
T
pe
rf
or
m
an
ce
(o
ve
ra
ll
ex
ec
ut
iv
e
dy
sf
un
ct
io
n)
N
ot
as
se
ss
ed
N
ot
as
se
ss
ed
N
ot
as
se
ss
ed
C
on
tr
ol
le
d
fo
r
IQ
S
Z
gr
ou
p
w
as
si
gn
ifi
ca
nt
ly
im
pa
ire
d
on
al
l
m
ea
su
re
s
of
ex
ec
ut
iv
e
fu
nc
tio
ni
ng
S
Z
>
H
C
on
re
sp
on
se
la
te
nc
y
(B
D
sc
or
ed
in
th
e
m
id
dl
e
w
ith
ns
.
di
ffe
re
nc
es
w
ith
ei
th
er
S
Z
or
co
nt
ro
l)
S
Z
>
H
C
on
re
sp
on
se
er
ro
rs
(B
D
sc
or
ed
in
th
e
m
id
dl
e
w
ith
ns
.
di
ffe
re
nc
es
w
ith
ei
th
er
S
Z
or
co
nt
ro
l)
B
D
gr
ou
p
di
d
no
t
di
ffe
r,
fr
om
H
C
S
Z
>
B
D
,H
C
on
se
m
an
tic
al
ly
re
la
te
d
er
ro
rs
R
os
se
ll
an
d
B
at
ty
(2
5)
S
Z
<
B
D
,H
C
on
th
e
se
m
an
tic
re
tr
ie
va
l(
m
or
e
ex
ec
ut
iv
e
ta
sk
)
S
Z
=
B
D
=
H
C
on
w
or
d
co
m
pr
eh
en
si
on
ac
ro
ss
gr
am
m
at
ic
al
ca
te
go
rie
s
(d
ep
en
d
on
ex
ec
ut
iv
e
re
gu
la
tio
n)
S
Z,
B
D
<
H
C
on
se
m
an
tic
re
co
gn
iti
on
,b
ot
h
cl
in
ic
al
gr
ou
ps
pr
es
en
te
d
si
m
ila
r
pe
rf
or
m
an
ce
w
ith
di
ffi
cu
lti
es
in
id
en
tif
yi
ng
th
e
co
rr
ec
t
w
or
d
m
ea
ni
ng
in
th
e
pr
es
en
ce
of
al
te
rn
at
iv
es
N
ot
as
se
ss
ed
N
ot
as
se
ss
ed
B
D
an
d
H
C
m
at
ch
ed
fo
r
IQ
,
an
d
di
ffe
re
nt
fr
om
S
Z
C
on
tr
ol
le
d
fo
r
IQ
S
Z
an
d
B
D
sh
ow
a
sh
or
tf
al
li
n
ab
ili
ty
to
or
ga
ni
ze
an
d
ca
te
go
riz
e
w
or
d
m
ea
ni
ng
s
S
an
ch
ez
-M
or
la
et
al
.(
23
)
S
Z,
B
D
<
H
C
on
al
lt
as
ks
S
Z
<
B
D
:e
xe
cu
tiv
e
co
nt
ro
l,
ve
rb
al
w
or
ki
ng
m
em
or
y
S
Z
=
B
D
on
ex
ec
ut
iv
e
co
nt
ro
l,
pl
an
ni
ng
an
d
pr
ob
le
m
so
lv
in
g,
an
d
se
m
an
tic
flu
en
cy
S
Z
<
B
D
<
H
C
in
im
m
ed
ia
te
an
d
de
la
ye
d
vi
su
al
m
em
or
y
S
Z
vs
.B
D
:m
ix
ed
re
su
lts
in
Ve
rb
al
M
em
or
y
Te
st
s
S
Z,
B
D
<
H
C
A
tt
en
tio
n
de
fic
its
in
S
Z
an
d
B
D
pt
pe
rs
is
te
d
du
rin
g
th
e
en
tir
e
co
ur
se
of
th
e
di
se
as
e
in
cl
ud
in
g
du
rin
g
pe
rio
ds
of
eu
th
ym
ia
N
ot
as
se
ss
ed
S
Z,
B
D
<
H
C
C
on
tr
ol
le
d
fo
r
IQ
D
ur
at
io
n
of
ill
ne
ss
co
rr
el
at
ed
w
ith
ex
ec
ut
iv
e,
ve
rb
al
m
em
or
y
an
d
vi
su
al
m
em
or
y
fu
nc
tio
ni
ng
in
B
D
B
D
w
ith
hi
st
or
y
of
ps
yc
ho
si
s
=
B
D
w
ith
ou
t
hi
st
or
y
ps
yc
ho
si
s
(C
on
tin
ue
d)
Frontiers in Psychiatry | Schizophrenia August 2013 | Volume 4 | Article 87 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vöhringer et al. Cognitive comparison between bipolar disorder and schizophrenia
Ta
b
le
2
|C
o
n
ti
n
u
ed
S
tu
d
y
E
xe
cu
ti
ve
fu
n
ct
io
n
s
an
d
la
n
g
u
ag
e
M
em
o
ry
A
tt
en
ti
o
n
Pe
rc
ep
tu
o
m
o
to
r
fu
n
ct
io
n
s
IQ
N
o
te
s
S
im
on
se
n
et
al
.(
19
)
S
Z,
S
ZA
,B
D
H
P
S
+,
<
B
D
,H
P
S
−,
H
C
on
se
t
sh
ift
in
g
ve
rb
al
flu
en
cy
B
D
H
P
S
−
=
H
C
on
al
l
ne
ur
oc
og
ni
tiv
e
su
bs
co
re
s,
ap
ar
t
fr
om
di
gi
t
sy
m
bo
lw
he
re
th
ey
pe
rf
or
m
ed
po
or
er
S
Z,
S
ZA
,B
D
w
ith
ps
yc
ho
si
s
<
B
D
,H
C
on
ve
rb
al
le
ar
ni
ng
an
d
m
em
or
y
B
D
pt
ar
e
re
po
rt
ed
to
ha
ve
in
te
rm
ed
ia
te
re
su
lts
be
tw
ee
n
th
e
tw
o
gr
ou
ps
N
ot
as
se
ss
ed
B
ot
h
ps
yc
ho
tic
an
d
no
n-
ps
yc
ho
tic
pt
re
po
rt
ed
lo
w
er
pe
rc
ep
tu
om
ot
or
fu
nc
tio
ns
as
co
m
pa
re
d
to
H
C
.N
o
si
gn
ifi
ca
nt
di
ffe
re
nc
es
w
er
e
sh
ow
n
be
tw
ee
n
th
em
.O
th
er
pt
w
ith
a
hi
st
or
y
of
ps
yc
ho
si
s
(S
Z,
S
ZA
)
pe
rf
or
m
ed
po
or
ly
th
an
H
C
on
m
ea
su
re
s
of
pr
oc
es
si
ng
sp
ee
di
ng
.I
n
pa
rt
ic
ul
ar
,S
Z
pt
sh
ow
ed
lo
w
er
D
yg
it
Sy
m
bo
l
Te
st
–
W
A
IS
-II
Is
co
re
s
as
co
m
pa
re
d
to
ps
yc
ho
tic
B
D
pt
S
Z
<
B
D
,H
C
C
on
tr
ol
le
d
fo
r
IQ
A
ll
pa
tie
nt
s
w
ith
a
hi
st
or
y
of
ps
yc
ho
si
s
pe
rf
or
m
ed
po
or
ly
on
al
lm
ea
su
re
s
W
ob
ro
ck
et
al
.
(2
2)
S
Z
ch
ro
ni
c
an
d
fir
st
ep
is
od
e
<
H
C
on
sp
ee
d,
ve
rb
al
flu
en
cy
,a
nd
ve
rb
al
w
or
ki
ng
m
em
or
y
W
ith
re
ga
rd
to
co
gn
iti
ve
fle
xi
bi
lit
y,
S
Z
pt
sh
ow
ed
m
or
e
pe
rs
ev
er
at
iv
e
re
sp
on
se
s
w
ith
po
or
er
W
C
ST
sc
or
es
as
co
m
pa
re
d
to
B
D
pt
an
d
H
C
B
ot
h
fir
st
ep
is
od
e
an
d
ch
ro
ni
c
S
Z
pt
ha
ve
de
cr
ea
se
d
ve
rb
al
le
ar
ni
ng
an
d
m
em
or
y
pe
rf
or
m
an
ce
s
as
co
m
pa
re
d
to
H
C
.B
D
pt
ar
e
re
po
rt
ed
to
ha
ve
in
te
rm
ed
ia
te
re
su
lts
be
tw
ee
n
th
e
tw
o
gr
ou
ps
S
Z
pt
ch
ro
ni
c
an
d
fir
st
ep
is
od
e
<
H
C
on
at
te
nt
io
n
S
Z
pt
ch
ro
ni
c
an
d
fir
st
ep
is
od
e
<
H
C
on
ps
yc
ho
m
ot
or
pe
rf
or
m
an
ce
S
Z
pt
sh
ow
ed
si
gn
ifi
ca
nt
po
or
er
re
su
lts
co
m
pa
re
d
to
H
C
S
Z
pt
ov
er
al
l
sh
ow
ed
a
po
or
er
pe
rf
or
m
an
ce
th
an
B
D
an
d
H
C
Za
ne
lli
et
al
.
(2
8)
S
Z
<
B
D
on
m
ea
su
re
s
of
vo
ca
bu
la
ry
an
d
co
m
pr
eh
en
si
on
,d
ig
it
sy
m
bo
l,
le
tt
er
-n
um
be
r
sp
an
,a
nd
bl
oc
k
de
si
gn
B
D
<
H
C
on
m
ea
su
re
s
of
de
la
ye
d
ve
rb
al
m
em
or
y
S
Z
<
B
D
<
H
C
in
ov
er
al
l
m
ea
su
re
s
N
ot
as
se
ss
ed
S
Z
pt
sh
ow
ed
si
gn
ifi
ca
nt
po
or
er
re
su
lts
co
m
pa
re
d
to
H
C
in
al
l
ex
am
in
ed
st
ud
ie
s
S
im
ila
r
pa
tt
er
n
be
tw
ee
n
cl
in
ic
al
gr
ou
ps
w
er
e
re
po
rt
ed
w
ith
re
ga
rd
to
cu
rr
en
t
IQ
S
Z
ac
ut
e
an
d
ch
ro
ni
c
sh
ow
ed
po
or
er
pe
rf
or
m
an
ce
th
an
th
e
re
st
B
D
<
H
C
on
m
ea
su
re
s
of
ca
te
go
ry
flu
en
cy
S
Z
<
H
C
on
th
e
Le
tt
er
-N
um
be
r
S
pa
n
Te
st
D
P
<
H
C
on
m
ea
su
re
s
of
ve
rb
al
le
ar
ni
ng
an
d
ca
te
go
ry
flu
en
cy
,a
nd
on
th
e
TM
T-
B
O
P
<
H
C
on
ve
rb
al
le
ar
ni
ng
B
D
<
H
C
on
ca
te
go
ry
flu
en
cy
H
C
,
he
al
th
y
co
nt
ro
ls
;
S
Z,
sc
hi
zo
ph
re
ni
a;
B
D
,
bi
po
la
r
di
so
rd
er
;
S
ZA
,
sc
hi
zo
af
fe
ct
iv
e
di
so
rd
er
;
S
ZF
,
sc
hi
zo
ph
re
ni
fo
rm
di
so
rd
er
;
P
t,
pa
tie
nt
s;
N
A
R
T,
N
at
io
na
lA
du
lt
R
ea
di
ng
Te
st
;
S
D
M
T,
Sy
m
bo
lD
ig
it
M
od
al
iti
es
Te
st
;
TM
T-
A
,T
ra
il
M
ak
in
g
Te
st
pa
rt
A
;T
M
T-
B
,T
ra
il
M
ak
in
g
Te
st
pa
rt
B
;
H
D
R
S,
H
am
ilt
on
D
ep
re
ss
iv
e
R
at
in
g
S
ca
le
;Y
M
R
S,
Yo
un
g
M
an
ia
R
at
in
g
S
ca
le
;
S
C
W
T,
S
tr
oo
p
C
ol
or
-W
rit
e
Te
st
;
C
P
T,
C
on
tin
uo
us
Pe
rf
or
m
an
ce
Te
st
;
W
A
IS
-R
,W
ec
hs
le
rA
du
lt
In
te
lli
ge
nc
e
S
ca
le
R
ev
is
ed
;W
C
ST
,W
is
co
ns
in
C
ar
d
S
or
tin
g
Te
st
.
www.frontiersin.org August 2013 | Volume 4 | Article 87 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vöhringer et al. Cognitive comparison between bipolar disorder and schizophrenia
(±2.7), p< 0.001, after adjusting for demographic variables, cur-
rent symptom measures, and illness course variables) (19). BD
patients performed intermediately between the two groups (17).
MEMORY
There is strong evidence that both first episode and chronic SZ
patients have decreased verbal learning and memory performances
as compared to HC. BD patients are reported to have intermediate
results between the two groups (17, 19, 22–25).
In particular, a study conducted in Australia on 32 SZ and 28 BD
patients explored the semantic retrieval (Generate condition) and
the semantic recognition (Forced choice condition): SZ patients
performed significantly poorer compared to HC on semantic
retrieval (MRC Oxford Psycholinguistic Database Generate con-
dition total score: 49.7 (±20.4) and 74.1 (±17.8), respectively,
p< 0.001; after adjusting for premorbid IQ) (25). Similar find-
ings were reported in other studies (26, 27). On the contrary, BD
patients did not present significant impairment. With regard to
semantic recognition, both clinical groups presented similar per-
formance with difficulties in identifying the correct word meaning
in the presence of alternatives (MRC Oxford Psycholinguistic
Database Forced choice condition total score: 72.7 (±16.0) and
75.1 (±17.0), respectively vs. 88.0 (±5.6) in HC, p< 0.001; after
adjusting for premorbid IQ) (25).
Sanchez-Morla et al. examined visual memory on 88 SZ and 73
BD patients using Rey-Osterreith Complex Figure Test (ROCFT).
They found significant differences in immediate and delayed visual
memory among the three groups, with BD patients performing
intermediately between SZ patients and HC (23).
IQ
Several studies analyzed premorbid IQ in SZ and BD patients using
tests based on measures of current ability though to be relatively
insensitive to brain dysfunction (17, 23).
Patients affected by SZ showed significant poorer results com-
pared to HC in all examined studies (22, 28). Two studies showed
that BD patients disclosed lower scores compared to HC (Vocab-
ulary Subtest – WAIS-R: 103.8 (±19.5) and 108.9 (±17.8), respec-
tively, p< 0.0001; National Adult Reading Test – NART IQ: 103.29
(±11.88) and 107.74 (± 9.98), respectively,p< 0.05) (17,23). Sim-
ilar pattern between clinical groups were reported with regard to
current IQ (17, 28).
ATTENTION
Some authors reported that attention deficits in SZ and BD
patients persisted during the entire course of the disease including
during periods of euthymia (16, 23, 24, 29, 30).
Researchers described similar degree of sustained attention
impairment in SZ and BD patients. In particular, a study con-
ducted in Spain in 2009 measured – using the Continuous Perfor-
mance Test (CPT) – lower number of hits and a longer reaction
time in both SZ and BD patients as compared to HC (CPT:
hits: 26.2 (±10.4), 30.7 (±8.7), and 34.6 (±6.2), respectively,
p< 0.037; Furthermore, the reaction time was longer for SZ and
BD compared with HC (ms): 550 (±94), 540 (±98), and 480
(±65), respectively, p< 0.0001; after adjusting for the effect of
age, years of education, gender, subclinical depressive symptoma-
tology, and premorbid IQ) (23). Others reported similar finding
using different tests that required keeping attention focused for an
extended amount of time (Repeatable Battery for the Assessment
of Neuropsychological Status; RBANS, Subtest Attention, Digit
Spam, and Coding) (24).
Based on results of the Stroop Test, Brissos et al. described
increased slowness and perseveration in incongruent tasks in SZ
patients as compared to BD patients (with or without history of
psychotic symptoms) and HC and interpreted it as a proxy of
deficient inhibitory control, strongly related with poor selective
attention (20).
PERCEPTUOMOTOR FUNCTIONS
Simonsen et al. divided the BD study population in psychotic and
non-psychotic subjects. Both categories reported lower percep-
tuomotor functions as compared to controls. No significant dif-
ferences were shown between them. Other patients with a history
of psychosis (SZ, schizoaffective disorder) performed poorly than
HC on measures of processing speeding. In particular, SZ patients
showed lower Dygit Symbol Test – WAIS-III scores as compared
to psychotic BD patients [56.1 (±14.5) and 63.7 (±16.2), respec-
tively,p< 0.001; after adjusting for demographic variables, current
symptom measures, illness course variables]. These results are con-
sistent with findings from Brissos et al. that, using different tests,
revealed a significant worse performance for SZ patients relative
to HC [Symbol Digit Modalities Test – SDMT: 30.6 (±11.71) and
56.4 (±14.82), respectively, p< 0.001; Trail Making Test part A –
TMT-A: 78.8 (±50.76) and 38.0 (±15.34), respectively, p< 0.001;
after adjusting for sex, age, educational level, Hamilton Depres-
sive Rating Scale – HDRS, Young Mania Rating Scale – YMRS, as
covariates) (20). Evidence from Germany supported such patterns
reporting lower performances for both first-episode and chronic
SZ patients as compared to HC (22).
DISCUSSION
Overall, patients with BD exhibit neurocognitive impairment
qualitatively similar to but quantitatively less pronounced than
patients with SZ. In a general sense, it seems that while emo-
tional and interpersonal difficulties in childhood reflect a general
predisposition to adult psychiatric illness, early developmental
impairments in psychomotor, language, and cognitive function
show some specificity to SZ outcomes and are not seen in those
who later develop BD. (31)
A previous meta-analysis showed that SZ patients demonstrate
worse cognitive performance than BD patients in most domains,
with substantial heterogeneity. This study focused on performance
differences between patients groups,without normal controls, thus
deviations from the norm were not analyzed (32). The course
of cognitive impairment also differs between groups: premorbid
cognitive impairment is present early in life in SZ (often child-
hood/adolescence), preceding onset of psychosis, but cognitive
impairment typically does not occur until later in adulthood in
BD, after many years of mood episodes (8).
Despite overlap between BD and SZ in genetics and phenome-
nology of psychosis (31), these cognitive impairment data indicate
that BD and SZ are different in severity and course of cognition.
During adulthood, BD patients have shown impairment on
neuropsychological measures sensitive to frontal lobe dysfunction
during the adolescence, usually before the diagnosis is made. This
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may suggest the presence of some kind of neurodevelopmental vul-
nerability, expressed initially as attentional deficits or comorbidity
with attention deficit-hyperactivity disorder (33). Nevertheless,
there is lack of systematic studies regarding time varying patterns
upon developmental deficits, starting on pre-morbid stage, and
continuing during the illness phases of both conditions. Regarding
specific domains of cognitive impairment, in SZ working memory
was impaired, while in BD attention was impaired (34)
The usual clinical symptomatology showed by these illnesses
can also modify cognitive functioning. For instance, severity of
negative symptoms in SZ may have some correlation with poor
neurocognitive performance, while on the contrary, severity of
depressive symptoms in BD showed no association with per-
formances on any neuropsychological test (28). A high level of
negative symptomatology might be seen as predictor of worse
response (17, 19); there are prior data suggesting that negative
symptoms had strong predictive capacity of neurocognitive out-
comes associated with measures of executive functioning and
selective attention, but not associated with visual or verbal learn-
ing and memory, verbal fluency, or processing speed (35). Further,
changes in depressive symptoms were correlated with poorer ver-
bal fluency, while no relationship between manic symptoms and
neuropsychological performance was detected (36).
Evidence suggests that patients were usually taking psychi-
atric medication while cognitively assessed, eventually biasing the
measure of differences between groups. This lack of clean assess-
ment, impede drawing any definitive conclusion of the effects
of medication on cognitive function. One study suggested the
presence of the pharmacological treatment over cognitive func-
tioning. (37) concluded that schizophrenic patients in polyphar-
macy had significantly lower cognitive functions than those in
the second-generation antipsychotics monotherapy (37). Addi-
tionally, moderate improvement was found in cognitive test per-
formance of patients on their first episode of SZ treated with
second-generation antipsychotics (38). Similarly, untreated bipo-
lar patients showed better cognitive performance than patients on
atypical antipsychotics (39).
Interesting evidence on the effect of psychopharmacologic
agents over cognitive function has been developed with lithium.
Studies suggest that cognitive deficits are not explained by this
medication, but by the condition itself (15, 40). With respect to
other drugs, cognitive side effects may occur as a direct conse-
quence of the mechanism of action of the psychotropic agent, or
indirectly through side effects such as sedation (41). Nevertheless,
post-onset neuropsychological evaluation may be confounded by
medication, making it difficult to comment about the relevance
of neuropsychological deficits when talking about the etiology or
development of these conditions. We think that further random-
ized research on drug naive patients should clarify the role of
medication on cognitive deficits. Moreover, typically early models
for the etiology of psychotic illnesses focused on dopamine neu-
rotransmission because of the powerful antipsychotic action of
dopamine antagonists giving support to the so-called dopamine
hypothesis of psychosis. Nevertheless, recent evidence increasingly
supports a primarily glutamatergic dysfunction in this condi-
tion, where dopaminergic disbalance is a secondary effect. (42)
In fact, a more recent model for the pathophysiology of SZ and
BD involves a pathophysiologic mechanism by which the cognitive
decline is representing the core of the clinical morbidity and
in this context impairment of glutamate and more specifically
N -methyl-d-aspartate (NMDA) function has been considered of
major importance. Given that astrocytes are crucial in controlling
glutamate homeostasis, seems to logical to assign a major role to
glial–neuronal interactions in the pathophysiology of the cognitive
decline in these conditions (43)
Few studies evaluated psychosocial function of patients. When
assessed, verbal memory impairment seemed to correlate with
a poorer psychosocial functionality. Furthermore, BD patients
scored lower than SZ patients; we thought that depressive or sub
threshold depressive symptoms might play a role on these results.
Executive function had a directly positive effect on psychosocial
adjustment in both patients with BD and SZ. There were posi-
tive correlations between insight and executive function among
subjects with SZ and BD, suggesting that the ability to recognize
their own experiences of illness seems to be the first step to devel-
oping an effective strategy for supplementing their deficiencies in
psychosocial adjustment (44). The possibility of a shared general
cognitive impairment might yet be possible as an explanation, due
to comparable qualitative scores shown by the two conditions; nev-
ertheless these abnormalities oftentimes are larger in SZ patients.
Following the same vein, a study suggests the existence of a con-
tinuum between SZ and affective disorders but with substantial
difference between the courses of their cognitive deficits, being
more severe in SZ and milder in BD (28). On the other hand,
a study contradicts this theory suggesting that BD patients usu-
ally present impaired performance on multiple cognitive domains,
whereas their first-degree relatives shown performances compa-
rable to HC on most cognitive tasks (3) additional research is
warranted in order to reach a sound conclusion on this matter.
Evidence regarding the effect of past psychotics symptoms on
the neurocognitive performance remains unclear. A study found
similar performance in all BD patients; no differences were found
depending on the history of the disease (16). On the contrary,
there is evidence concluding that patients with a psychotic bipo-
lar condition represent a group that is neurocognitive closer to
the SZ than the non-psychotic bipolar subjects. This study was
carried out with symptomatic patients and therefore this clinical
condition may confound these results (19).
The overall homogeneity among these findings argues favor-
ably for the validity of a milder neuropsychological impairment
in BD compared with SZ and yet other considerations like the
eventual cognitive continuum between BD and SZ, the role of
psychotropic medication, the pre-morbid deficit and the possible
effect of psychotic symptomatology over the neuropsychological
status remains unclear.
Limitations of the present systematic review includes hetero-
geneity of samples and assessments, the impossibility to control
for acute or chronic effects of medication, varying time required
for assessment across different studies, illness diagnosis stability,
and course severity. Another limitation to be considered pertains
with the time limit that was set up for the systematic review. In
effect, to gain novelty about the selected studies, search time was
set up with year 2008 as the lower limit and important papers
about glial research have appeared before the 2008, thus some rel-
evant evidence regarding this pathophysiological mechanism may
be left out of the overall search.
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